University of Washington Tests Oral Bacterial Transplants

Researchers are investigating whether bacterial transfers can effectively treat chronic halitosis.

Updated on Oct. 28, 2026 in Life Sciences

University of Washington Tests Oral Bacterial Transplants

Live Poll

Would you be willing to participate in a medical study involving an oral bacteria transplant?

Researchers at the University of Washington are conducting a clinical trial that uses oral bacterial transplants to treat chronic halitosis. The procedure aims to rebalance the oral microbiome by introducing healthy bacteria to the patient.

Why it matters

The team believes that chronic bad breath is caused by an imbalance in oral microbiome proportions. Addressing this at the bacterial level could offer a long-term solution for those suffering from the condition.

The clinical trial included an initial group of four participants. Researchers are now seeking federal approval for an expanded cohort to study the treatment over an expected period of two years.

The players

University of Washington

This is a public research university that serves as the site for the ongoing clinical trial.

The details

The procedure requires harvesting healthy bacteria from a donor before cleaning the recipient's teeth. The healthy bacteria are then delivered to the recipient through a saline mouth rinse and a gumline concentrate.

Participants report treatment results three months after the procedure.
Continued research testing is expected to last for the next two years.

The Big Picture

This clinical trial extends ongoing efforts within the human oral microbiome research programs by testing a therapeutic application of microbial population balancing. The study marks a shift from symptom-based treatments toward restoring the natural biological balance of the mouth.

If successful, this method could lead to new clinical treatments for chronic halitosis that move beyond temporary oral hygiene products. Future availability will depend on the results of the expanded cohort studies and subsequent federal approvals.

The takeaway

This research highlights the growing focus on the human microbiome as a target for treating chronic conditions. If you struggle with persistent health issues, keep an eye on clinical trial announcements from your local university research hospitals.